drugset / Trial / NCT04005430
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
NaSingle-groupOpen-labelTreatment
Summary
This phase I trial will assess primarily the safety and secondarily anti-inflammatory effect of Episcleral Dexamethasone in patients suffering from refractory diabetic macular edema.
Timeline
- Start
- 2019-04-03
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Other |